Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis a
Comorbidity C0023895|liver disease
Sentences 26
PubMedID- 20228784 All of the tumors in cirrhotic livers had chronic viral hepatitis as an underlying cause of liver disease (table 1).
PubMedID- 22511902 We also excluded patients with human immune-deficiency virus infection, hepatitis b virus co-infection, alcohol abuse, autoimmue hepatitis and other causes of liver disease.
PubMedID- 19447449 [fatal acute hepatitis and cholestasis associated with liver disease].
PubMedID- 25131040 The population had an average age of 57.5 years, predominantly formed by men (82.5%), with an average imc of 26.7, meld of 13, with viral hepatitis as main cause of liver disease.
PubMedID- 24742346 hepatitis a infection in patients with chronic viral liver disease: a cross-sectional study in jahrom, iran.
PubMedID- 21167429 Severe forms of hepatitis are associated with underlying chronic liver disease such alcoholic disease.
PubMedID- 23559770 The common indications for liver transplantations were alcoholic cirrhosis, chronic liver disease associated with viral hepatitis and cryptogenic chronic liver disease [table 1].
PubMedID- 21057383 A better understanding of the importance of preventing acute hepatitis a and b in patients with chronic liver disease and a proactive approach to vaccination by primary care physicians can positively influence the outcome of patients with chronic liver disease.
PubMedID- 22906987 (aih) and viral hepatitis are inflammatory liver diseases in which liver damage is dependent to a great extent upon the infiltration of liver by cd4+ t cells producing the cytokine ifn-γ [1–3], also known as th1 cells.
PubMedID- 23161302 Conclusions: pegylated interferon is as effective in patients with advanced liver disease due to chronic delta hepatitis as in patients with non-advanced liver disease, but patients should be monitored closely for clinically important side effects.
PubMedID- 22346770 Alcoholic and nonalcoholic steatohepatitis are leading causes of liver diseases worldwide (41,82).
PubMedID- 24742271 Most of these infections cause chronic hepatitis and leading to progressive liver disease including cirrhosis, fibrosis and finally hepatocellular carcinoma (hcc) [3-5].
PubMedID- 21145841 Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
PubMedID- 24069490 These criteria also include symptoms of severe liver disease due to viral hepatitis a, b, c, and e (jaundice, hepatic encephalopathy, bleeding due to impaired synthesis of coagulation factors, and renal failure due to hepatorenal syndrome).
PubMedID- 23752047 Overlap syndromes are biochemical, serological, histological and radiological overlaps across the classic autoimmune liver diseases in the presence of autoimmun hepatitis and primary biliary cirrhosis or primary sclerosing cholangitis.
PubMedID- 25240529 Pnpla3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
PubMedID- 22448309 Reported four adults being assessed for liver transplantation because of chronic liver diseases (three with cryptogenic hepatitis and one with congenital hepatic fibrosis) in whom cd was diagnosed following serological screening and gluten withdrawal led to improvement of hepatic function, eliminating the need for liver transplantation.
PubMedID- 24456332 Alcohol-related liver disease (ald) is associated with steatohepatitis and insulin resistance.
PubMedID- 20215064 Chronic liver disease might be due to hemosiderosis and hepatitis and possibly to scd itself if small, clinically silent microvascular occlusions occur chronically.
PubMedID- 25801076 Background: the pnpla3/adiponutrin rs738409 c/g single nucleotide polymorphism is associated with the severity of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease, as well as the severity of steatosis and fibrosis in patients with chronic hepatitis c (chc).
PubMedID- 22452877 The elevated expression of cyp2e1, a microsomal oxidase involved in fatty acid ω-oxidation, as well as cyp4a, has been shown to be largely responsible for the pathogenesis of liver disease in patients with nonalcoholic steatohepatitis and plays a key role in the development of liver injury by initiating lipid peroxidation [3-7].
PubMedID- 25862175 The pnpla3 p.ile148met variant and obesity: brothers-in-arms: comment on: pnpla3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
PubMedID- 24890045 Methods: studies cited in pub med from 1972 to 2014 for autoimmune hepatitis, chemokines in liver disease, pathogenesis of autoimmune hepatitis and chemokine therapy were selected.
PubMedID- 24786290 While hepatitis a infection is not associated with chronic liver disease in general, older and immunosuppressed people are susceptible to develop a fatal progression.
PubMedID- 22097893 Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
PubMedID- 26057287 Objectives: to illustrate how to identify patients with nonalcoholic fatty liver disease at greatest risk of nonalcoholic steatohepatitis and cirrhosis; to discuss the role and limitations of current diagnostics and liver biopsy to diagnose nonalcoholic steatohepatitis; and to provide an outline for the management of patients across the spectrum of nonalcoholic fatty liver disease.

Page: 1